These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 24255171)

  • 1. Cocarcinogenic effects of intrahepatic bile acid accumulation in cholangiocarcinoma development.
    Lozano E; Sanchez-Vicente L; Monte MJ; Herraez E; Briz O; Banales JM; Marin JJ; Macias RI
    Mol Cancer Res; 2014 Jan; 12(1):91-100. PubMed ID: 24255171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of FXR or TGR5 activation in cholangiocarcinoma progression.
    Erice O; Labiano I; Arbelaiz A; Santos-Laso A; Munoz-Garrido P; Jimenez-Agüero R; Olaizola P; Caro-Maldonado A; Martín-Martín N; Carracedo A; Lozano E; Marin JJ; O'Rourke CJ; Andersen JB; Llop J; Gómez-Vallejo V; Padro D; Martin A; Marzioni M; Adorini L; Trauner M; Bujanda L; Perugorria MJ; Banales JM
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1335-1344. PubMed ID: 28916388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of MAFG Dysregulation in Cholestatic Liver Injury and Development of Liver Cancer.
    Liu T; Yang H; Fan W; Tu J; Li TWH; Wang J; Shen H; Yang J; Xiong T; Steggerda J; Liu Z; Noureddin M; Maldonado SS; Annamalai A; Seki E; Mato JM; Lu SC
    Gastroenterology; 2018 Aug; 155(2):557-571.e14. PubMed ID: 29733835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An oestrogen receptor β-selective agonist exerts anti-neoplastic effects in experimental intrahepatic cholangiocarcinoma.
    Marzioni M; Torrice A; Saccomanno S; Rychlicki C; Agostinelli L; Pierantonelli I; Rhönnstad P; Trozzi L; Apelqvist T; Gentile R; Candelaresi C; Fava G; Semeraro R; Benedetti A; Gaudio E; Franchitto A; Onori P; De Minicis S; Carpino G; Kallin E; Alvaro D; Nilsson S
    Dig Liver Dis; 2012 Feb; 44(2):134-42. PubMed ID: 21782536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conjugated bile acids promote cholangiocarcinoma cell invasive growth through activation of sphingosine 1-phosphate receptor 2.
    Liu R; Zhao R; Zhou X; Liang X; Campbell DJ; Zhang X; Zhang L; Shi R; Wang G; Pandak WM; Sirica AE; Hylemon PB; Zhou H
    Hepatology; 2014 Sep; 60(3):908-18. PubMed ID: 24700501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the nuclear receptor FXR enhances hepatocyte chemoprotection and liver tumor chemoresistance against genotoxic compounds.
    Vaquero J; Briz O; Herraez E; Muntané J; Marin JJ
    Biochim Biophys Acta; 2013 Oct; 1833(10):2212-9. PubMed ID: 23680185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oleanolic acid attenuates obstructive cholestasis in bile duct-ligated mice, possibly via activation of NRF2-MRPs and FXR antagonism.
    Chen P; Li J; Fan X; Zeng H; Deng R; Li D; Huang M; Bi H
    Eur J Pharmacol; 2015 Oct; 765():131-9. PubMed ID: 26297978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholangiocarcinoma development: the resurgence of bile acids.
    Maroni L; Alpini G; Marzioni M
    Hepatology; 2014 Sep; 60(3):795-7. PubMed ID: 24828905
    [No Abstract]   [Full Text] [Related]  

  • 9. Leptin enhances cholangiocarcinoma cell growth.
    Fava G; Alpini G; Rychlicki C; Saccomanno S; DeMorrow S; Trozzi L; Candelaresi C; Venter J; Di Sario A; Marzioni M; Bearzi I; Glaser S; Alvaro D; Marucci L; Francis H; Svegliati-Baroni G; Benedetti A
    Cancer Res; 2008 Aug; 68(16):6752-61. PubMed ID: 18701500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alisol B 23-acetate protects against ANIT-induced hepatotoxity and cholestasis, due to FXR-mediated regulation of transporters and enzymes involved in bile acid homeostasis.
    Meng Q; Chen XL; Wang CY; Liu Q; Sun HJ; Sun PY; Huo XK; Liu ZH; Yao JH; Liu KX
    Toxicol Appl Pharmacol; 2015 Mar; 283(3):178-86. PubMed ID: 25655198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases.
    Trauner M; Fickert P; Halilbasic E; Moustafa T
    Wien Med Wochenschr; 2008; 158(19-20):542-8. PubMed ID: 18998069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic bile duct injury associated with fibrotic matrix microenvironment provokes cholangiocarcinoma in p53-deficient mice.
    Farazi PA; Zeisberg M; Glickman J; Zhang Y; Kalluri R; DePinho RA
    Cancer Res; 2006 Jul; 66(13):6622-7. PubMed ID: 16818635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-6 contributes to growth in cholangiocarcinoma cells by aberrant promoter methylation and gene expression.
    Wehbe H; Henson R; Meng F; Mize-Berge J; Patel T
    Cancer Res; 2006 Nov; 66(21):10517-24. PubMed ID: 17079474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
    Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B
    Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation-related DNA damage and expression of CD133 and Oct3/4 in cholangiocarcinoma patients with poor prognosis.
    Thanan R; Pairojkul C; Pinlaor S; Khuntikeo N; Wongkham C; Sripa B; Ma N; Vaeteewoottacharn K; Furukawa A; Kobayashi H; Hiraku Y; Oikawa S; Kawanishi S; Yongvanit P; Murata M
    Free Radic Biol Med; 2013 Dec; 65():1464-1472. PubMed ID: 23917144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. cDNA microarray profiling of rat cholangiocarcinoma induced by thioacetamide.
    Yeh CN; Weng WH; Lenka G; Tsao LC; Chiang KC; Pang ST; Chen TW; Jan YY; Chen MF
    Mol Med Rep; 2013 Aug; 8(2):350-60. PubMed ID: 23754683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrahepatic cholangiocarcinoma: a worthy challenge.
    Bartlett DL
    Cancer J; 2009; 15(3):255-6. PubMed ID: 19556913
    [No Abstract]   [Full Text] [Related]  

  • 18. Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats.
    Verbeke L; Farre R; Trebicka J; Komuta M; Roskams T; Klein S; Elst IV; Windmolders P; Vanuytsel T; Nevens F; Laleman W
    Hepatology; 2014 Jun; 59(6):2286-98. PubMed ID: 24259407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition.
    Vaquero J; Monte MJ; Dominguez M; Muntané J; Marin JJ
    Biochem Pharmacol; 2013 Oct; 86(7):926-39. PubMed ID: 23928191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An animal model of benign bile-duct stricture, sclerosing cholangitis and cholangiocarcinoma and the role of epidermal growth factor receptor in ductal proliferation.
    Cheifetz RE; Davis NL; Owen DA
    Can J Surg; 1996 Jun; 39(3):193-7. PubMed ID: 8640617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.